These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7478571

  • 1. Tyrosine phosphorylation of murine Crkl.
    de Jong R, Haataja L, Voncken JW, Heisterkamp N, Groffen J.
    Oncogene; 1995 Oct 19; 11(8):1469-74. PubMed ID: 7478571
    [Abstract] [Full Text] [Related]

  • 2. Tyrosine 207 in CRKL is the BCR/ABL phosphorylation site.
    de Jong R, ten Hoeve J, Heisterkamp N, Groffen J.
    Oncogene; 1997 Feb 06; 14(5):507-13. PubMed ID: 9053848
    [Abstract] [Full Text] [Related]

  • 3. Interaction of Bcr/Abl with C3G, an exchange factor for the small GTPase Rap1, through the adapter protein Crkl.
    Cho YJ, Hemmeryckx B, Groffen J, Heisterkamp N.
    Biochem Biophys Res Commun; 2005 Aug 12; 333(4):1276-83. PubMed ID: 15982636
    [Abstract] [Full Text] [Related]

  • 4. C3G is tyrosine-phosphorylated after integrin-mediated cell adhesion in normal but not in Bcr/Abl expressing cells.
    de Jong R, van Wijk A, Heisterkamp N, Groffen J.
    Oncogene; 1998 Nov 26; 17(21):2805-10. PubMed ID: 9840945
    [Abstract] [Full Text] [Related]

  • 5. Cellular interactions of CRKL, and SH2-SH3 adaptor protein.
    ten Hoeve J, Kaartinen V, Fioretos T, Haataja L, Voncken JW, Heisterkamp N, Groffen J.
    Cancer Res; 1994 May 15; 54(10):2563-7. PubMed ID: 8168080
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells.
    Nichols GL, Raines MA, Vera JC, Lacomis L, Tempst P, Golde DW.
    Blood; 1994 Nov 01; 84(9):2912-8. PubMed ID: 7524758
    [Abstract] [Full Text] [Related]

  • 8. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
    Salgia R, Pisick E, Sattler M, Li JL, Uemura N, Wong WK, Burky SA, Hirai H, Chen LB, Griffin JD.
    J Biol Chem; 1996 Oct 11; 271(41):25198-203. PubMed ID: 8810278
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. BCR/ABL P190 transgenic mice develop leukemia in the absence of Crkl.
    Hemmeryckx B, Reichert A, Watanabe M, Kaartinen V, de Jong R, Pattengale PK, Groffen J, Heisterkamp N.
    Oncogene; 2002 May 09; 21(20):3225-31. PubMed ID: 12082638
    [Abstract] [Full Text] [Related]

  • 11. BCR/ABL-induced leukemogenesis causes phosphorylation of Hef1 and its association with Crkl.
    de Jong R, van Wijk A, Haataja L, Heisterkamp N, Groffen J.
    J Biol Chem; 1997 Dec 19; 272(51):32649-55. PubMed ID: 9405482
    [Abstract] [Full Text] [Related]

  • 12. Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-Abl.
    Gutiérrez-Berzal J, Castellano E, Martín-Encabo S, Gutiérrez-Cianca N, Hernández JM, Santos E, Guerrero C.
    Exp Cell Res; 2006 Apr 01; 312(6):938-48. PubMed ID: 16443220
    [Abstract] [Full Text] [Related]

  • 13. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells.
    Salgia R, Uemura N, Okuda K, Li JL, Pisick E, Sattler M, de Jong R, Druker B, Heisterkamp N, Chen LB.
    J Biol Chem; 1995 Dec 08; 270(49):29145-50. PubMed ID: 7493940
    [Abstract] [Full Text] [Related]

  • 14. Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy.
    Jilani I, Kantarjian H, Gorre M, Cortes J, Ottmann O, Bhalla K, Giles FJ, Albitar M.
    Leuk Res; 2008 Apr 08; 32(4):643-9. PubMed ID: 17900686
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E, Xu G, Li JL, Prasad KV, Griffin JD.
    Oncogene; 1996 Feb 15; 12(4):839-46. PubMed ID: 8632906
    [Abstract] [Full Text] [Related]

  • 18. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
    Oda T, Kujovich J, Reis M, Newman B, Druker BJ.
    Oncogene; 1997 Sep 15; 15(11):1255-62. PubMed ID: 9315092
    [Abstract] [Full Text] [Related]

  • 19. Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells.
    Sattler M, Salgia R.
    Leukemia; 1998 May 15; 12(5):637-44. PubMed ID: 9593259
    [Abstract] [Full Text] [Related]

  • 20. Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia.
    ten Hoeve J, Arlinghaus RB, Guo JQ, Heisterkamp N, Groffen J.
    Blood; 1994 Sep 15; 84(6):1731-6. PubMed ID: 7521685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.